TrialBMJ open2020

Postoperative intravenous parecoxib sodium followed by oral celecoxib post total knee arthroplasty in osteoarthritis patients (PIPFORCE): a multicentre, double-blind, randomised, placebo-controlled trial.

Qianyu Zhuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.